Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment

被引:585
作者
DeKosky, ST
Ikonomovic, MD
Styren, SD
Beckett, L
Wisniewski, S
Bennett, DA
Cochran, EJ
Kordower, JH
Mufson, EJ
机构
[1] Univ Pittsburgh, Med Ctr, Alzheimers Dis Res Ctr, Sch Med, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Dept Neurol, Sch Med, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Dept Psychiat, Sch Med, Pittsburgh, PA 15213 USA
[4] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA
[5] Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
[6] Rush Presbyterian St Lukes Med Ctr, Alzheimers Dis Ctr, Chicago, IL 60612 USA
关键词
D O I
10.1002/ana.10069
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In Alzheimer's disease (AD), loss of cortical and hippocampal choline acetyltransferase (ChAT) activity has been correlated with dementia severity and disease duration, and it forms the basis for current therapies. However, the extent to which reductions in ChAT activity are associated with early cognitive decline has not been well established. We quantified ChAT activity in the hippocampus and four cortical regions (superior frontal, inferior parietal, superior temporal, and anterior cingulate) of 58 individuals diagnosed with no cognitive impairment (NCI; n = 26; mean age 81.4 +/- 7.3 years), mild cognitive impairment (MCI; n = 18; mean age 84.5 +/- 5.7), or mild AD (n = 14; mean age 86.3 +/- 6.6). Inferior parietal cortex ChAT activity was also assessed in 12 subjects with end-stage AD (mean age 81.4 +/- 4.3 years) and compared to inferior parietal cortex ChAT levels of the other three groups. Only the end-stage AD group had ChAT levels reduced below normal. In individuals with MCI and mild AD, ChAT activity was unchanged in the inferior parietal, superior temporal, and anterior cingulate cortices compared to NCI. In contrast, ChAT activity in the superior frontal cortex was significantly elevated above normal controls in MCI subjects, whereas the mild AD group was not different from NCI or MCI. Hippocampal ChAT activity was significantly higher in MCI subjects than in either NCI or AD. Our results suggest that cognitive deficits in MCI and early AD are not associated with the loss of ChAT and occur despite regionally specific upregulation. Thus, the earliest cognitive deficits in AD involve brain changes other than simply cholinergic system loss. Of importance, the cholinergic system is capable of compensatory responses during the early stage of dementia. The upregulation in frontal cortex and hippocampal ChAT activity could be an important factor in preventing the transition of MCI subjects to AD.
引用
收藏
页码:145 / 155
页数:11
相关论文
共 73 条
  • [1] USE OF BRIEF COGNITIVE TESTS TO IDENTIFY INDIVIDUALS IN THE COMMUNITY WITH CLINICALLY DIAGNOSED ALZHEIMERS-DISEASE
    ALBERT, M
    SMITH, LA
    SCHERR, PA
    TAYLOR, JO
    EVANS, DA
    FUNKENSTEIN, HH
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1991, 57 (3-4) : 167 - 178
  • [2] [Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
  • [3] DIFFERENTIAL ALTERATION OF VARIOUS CHOLINERGIC MARKERS IN CORTICAL AND SUBCORTICAL REGIONS OF HUMAN-BRAIN IN ALZHEIMERS-DISEASE
    ARAUJO, DM
    LAPCHAK, PA
    ROBITAILLE, Y
    GAUTHIER, S
    QUIRION, R
    [J]. JOURNAL OF NEUROCHEMISTRY, 1988, 50 (06) : 1914 - 1923
  • [4] Consensus recommendations for the postmortem diagnosis of Alzheimer's disease
    Ball, M
    Braak, H
    Coleman, P
    Dickson, D
    Duyckaerts, C
    Gambetti, P
    Hansen, L
    Hyman, B
    Jellinger, K
    Markesbery, W
    Perl, D
    Powers, J
    Price, J
    Trojanowski, JQ
    Wisniewski, H
    Phelps, C
    Khachaturian, Z
    [J]. NEUROBIOLOGY OF AGING, 1997, 18 (04) : S1 - S2
  • [5] On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis
    Bartus, RT
    [J]. EXPERIMENTAL NEUROLOGY, 2000, 163 (02) : 495 - 529
  • [6] Around the WORLD backward: An algorithm for scoring the MMSE WORLD item
    Beckett, LA
    Wilson, RS
    Bennett, DA
    Morris, MC
    [J]. NEUROLOGY, 1997, 48 (06) : 1733 - 1734
  • [7] Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale
    Bennett, DA
    Shannon, KM
    Beckett, LA
    Goetz, CG
    Wilson, RS
    [J]. NEUROLOGY, 1997, 49 (06) : 1580 - 1587
  • [8] Dimensionality of parkinsonian signs in aging and Alzheimer's disease
    Bennett, DA
    Shannon, KM
    Beckett, LA
    Wilson, RS
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 1999, 54 (04): : M191 - M196
  • [9] CHOLINE-ACETYLTRANSFERASE ACTIVITY AND HISTOPATHOLOGY OF FRONTAL NEOCORTEX FROM BIOPSIES OF DEMENTED PATIENTS
    BOWEN, DM
    BENTON, JS
    SPILLANE, JA
    SMITH, CCT
    ALLEN, SJ
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1982, 57 (2-3) : 191 - 202
  • [10] STAGING OF ALZHEIMER-RELATED CORTICAL DESTRUCTION
    BRAAK, H
    BRAAK, E
    BOHL, J
    [J]. EUROPEAN NEUROLOGY, 1993, 33 (06) : 403 - 408